Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions

Abstract

Ten percent of patients abandon newly initiated oral oncolytics at the pharmacy. Patients facing higher cost sharing or increased concurrent prescription activity have a higher abandonment rate.